AzTrials
AzTrials

Semen Quality in Healthy Adult MenNCT07778576

Effects of 12-Week Combined Exercise on Semen Quality and Metabolic Health in Healthy Men

A study testing Combined Aerobic and Resistance Exercise Program in people with Semen Quality in Healthy Adult Men, run by Cumhuriyet University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluated whether a 12-week combined aerobic and resistance exercise program could improve semen quality and metabolic health in healthy adult men. A total of 34 men aged 18-24 years participated in the study. Read more about this study

Who is it for?
Ages 18 to 24 years, men onlyHealthy volunteers can take part
Conditions the study is for
Semen Quality in Healthy Adult Men
What is being tested?
Combined Aerobic and Resistance Exercise Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
34 participants
Where
1 siteTurkey (Türkiye)
Study dates
3 Mar 2025to 6 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 24 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male participants aged 18-24 years. Being generally healthy and able to participate safely in an aerobic and resistance exercise program.
  • Voluntarily agreeing to participate and providing written informed consent. Being willing and able to provide semen and blood samples at baseline and after the 12-week study period.
  • Being able to complete the study assessments and comply with the study procedures.

Who cannot join

  • Presence of a diagnosed reproductive system disorder or a medical condition known to affect semen quality.
  • Presence of a chronic, cardiovascular, metabolic, musculoskeletal, or other medical condition that could prevent safe participation in exercise.
  • Current use of medication, hormonal treatment, or nutritional supplementation known to influence reproductive or metabolic outcomes.
  • Presence of an acute illness or injury during the assessment or intervention period that prevented participation.
  • Failure to complete the baseline or post-intervention assessments. Failure to comply with the prescribed exercise program or study procedures.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Sivas Cumhuriyet University

    Sivas, 58140

Other trials in Turkey (Türkiye)

About this study

Official title: Semen Quality and Metabolic Biomarker Changes Following a 12-Week Combined Exercise Program in Healthy Adult Men

This study evaluated whether a 12-week combined aerobic and resistance exercise program could improve semen quality and metabolic health in healthy adult men. A total of 34 men aged 18-24 years participated in the study. Participants were assigned to either an exercise group or a passive control group based on their willingness and ability to attend the exercise program; assignment was not randomized.

Participants in the exercise group completed supervised combined exercise sessions three times per week for 12 weeks. Each session included aerobic and resistance exercises. Participants in the control group were asked to maintain their usual daily activities and not begin a structured exercise program during the study.

Semen quality, metabolic biomarkers, and body composition were assessed before and after the 12-week study period. Semen assessments included semen volume, pH, sperm concentration, motility, and normal sperm morphology. The study aimed to determine whether regular combined exercise was associated with changes in reproductive and metabolic health compared with no structured exercise program.

Read the detailed description

This completed, non-randomized, parallel-group interventional study investigated the effects of a 12-week supervised combined aerobic and resistance exercise program on semen quality, metabolic biomarkers, and body composition in healthy adult men.

A total of 34 men aged 18-24 years were enrolled. Participants were allocated to an exercise group or a passive control group according to their willingness and availability to participate in the supervised exercise program. Therefore, no random sequence generation or concealed allocation procedure was used.

Participants assigned to the exercise group completed a 12-week combined exercise program consisting of three supervised sessions per week. The program incorporated both aerobic and resistance exercise components. Exercise sessions were progressively organized over the intervention period to provide a structured training stimulus. Participants assigned to the passive control group continued their usual daily routines and were instructed not to participate in a new structured exercise program during the same period.

Assessments were conducted at baseline and after completion of the 12-week intervention. Semen samples were evaluated for semen volume, pH, sperm concentration, total motility, progressive motility, non-progressive motility, and normal sperm morphology. Metabolic biomarkers and body-composition measures were also evaluated at both time points.

Laboratory personnel responsible for outcome assessment were unaware of the participants' group assignments. Changes from baseline to the end of the intervention were compared between the exercise and control groups to examine whether combined exercise was associated with improvements in reproductive and metabolic health.

Being tested
Combined Aerobic and Resistance Exercise Program
Keywords
Combined Exercise, Aerobic Exercise, Resistance Exercise, Semen Quality, Sperm Concentration, Sperm Motility, Sperm Morphology, Male Reproductive Health, Metabolic Biomarkers, Body Composition, Healthy Adult Men

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Combined Aerobic and Resistance Exercise ProgramBehavioural

    Participants completed a 12-week supervised combined exercise program performed three times per week. Each session included aerobic and resistance exercise components. The training program was progressively structured across the intervention period to provide an appropriate exercise stimulus. Exercise sessions were supervised to support adherence and the correct performance of the prescribed activities. Semen quality, metabolic biomarkers, and body composition were assessed before and after the intervention.

Study groups in NCT07778576
Study groupRoleWhat they receive
Combined Exercise GroupExperimentalParticipants completed a 12-week supervised combined exercise program consisting of aerobic and resistance exercises performed three times per week. The exercise program was progressively structured throughout the intervention period. Semen quality, metabolic biomarkers, and body composition were assessed at baseline and after the 12-week intervention.
Receives: Behavioral: Combined Aerobic and Resistance Exercise Program
Passive Control GroupNo interventionParticipants continued their usual daily routines during the 12-week study period and were instructed not to begin or participate in a structured exercise program. They underwent the same baseline and post-intervention assessments as the combined exercise group, including semen quality, metabolic biomarkers, and body composition measurements.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Sperm Concentration

    Sperm concentration was determined through semen analysis and expressed as the number of spermatozoa per milliliter of semen. The change from baseline to the end of the 12-week study period was compared between the combined exercise and passive control groups.

    Measured: Baseline and Week 12

  2. Change in Total Sperm Motility

    Total sperm motility was assessed by semen analysis and expressed as the percentage of progressively and non-progressively motile spermatozoa. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

  3. Change in Progressive Sperm Motility

    Progressive sperm motility was assessed by semen analysis and expressed as the percentage of spermatozoa demonstrating progressive forward movement. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

  4. Change in Non-Progressive Sperm Motility

    Non-progressive sperm motility was assessed by semen analysis and expressed as the percentage of motile spermatozoa that did not demonstrate progressive forward movement. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

  5. Change in Normal Sperm Morphology

    Normal sperm morphology was assessed by semen analysis and expressed as the percentage of spermatozoa classified as having normal morphology. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

  6. Change in Semen Volume

    Semen volume was measured during semen analysis and expressed in milliliters. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

  7. Change in Semen pH

    Semen pH was measured during semen analysis using the laboratory procedure specified in the study protocol. Change from baseline was evaluated after the 12-week study period.

    Measured: Baseline and Week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2026
  2. Study start3 Mar 2025
  3. Primary completion6 Jun 2025
  4. Study completion6 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Participants were assigned to either a supervised combined exercise group or a passive control group based on their willingness and availability to attend the exercise program. The two groups were followed in parallel for 12 weeks. Group allocation was not randomized.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
34 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07778576
Sponsor's protocol ID
2024-03-02
Status last verified
Aug 2026
First submitted
18 Aug 2026
Last updated
24 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Combined Aerobic and Resistance Exercise Program in people with Semen Quality in Healthy Adult Men, run by Cumhuriyet University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Sperm Concentration (time frame: Baseline and Week 12). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in